The ATC is pleased to announce Doris Taylor as a State of the Art Speaker for 2011.
Doris Taylor, PhD, Director, Center for Cardiovascular Repair, Medtronic Bakken Professor of Integrative Biology and Physiology, and Professor of Medicine at the University of Minnesota.
Doris Taylor and team bring science from bench to bedside. She gained international recognition by developing a process called whole-organ decellularization and creating a beating heart in the laboratory. In this process, they rinsed all cells away from a rat heart and reseeded the remaining scaffold with a mixture of cells. Taylor demonstrated this approach works for other organs.
Dr. Taylor will address "Rebuilding Autologous Organs: Cells, Scaffold, Organ" during the State of the Art Address on Monday, May 2, 2011.
The ATC is pleased to announce Arthur Caplan as the Keynote Speaker for 2011.
Currently the Robert Hart Director of the Center for Bioethics and the Sidney D. Caplan Professor of Bioethics at the University of Pennsylvania in Philadelphia.
He is the author or editor of thirty books and over 550 papers in refereed journals. His most recent books are Smart Mice Not So Smart People (Rowman Littlefield, 2006) and the Penn Guide to Bioethics (Springer, 2009).
He has served on a number of national and international committees including as the Chair, National Cancer Institute Biobanking Ethics Working Group; the Chair of the Advisory Committee to the United Nations on Human Cloning; the Chair of the Advisory Committee to the Department of Health and Human Services on Blood Safety and Availability; a member of the Presidential Advisory Committee on Gulf War Illnesses; the special advisory committee to the International Olympic Committee on genetics and gene therapy; and the special advisory panel to the National Institutes of Mental Health on human experimentation on vulnerable subjects. Most recently he was the Co-Director of the Joint Council of Europe/United Nations Study on Trafficking in Organs and Body Parts.
Mr. Caplan will address "The Not-So Distant Future of Organ Transplantation--Ethical Obstacles and Opportunities" during the Keynote on Wednesday, May 4, 2011.
ATC is pleased to Announce Joseph P Vacanti as a State of the Art Speaker for 2011.
Joseph P. Vacanti is Chief of the Department of Pediatric Surgery at Massachusetts General Hospital, Surgeon-in-Chief at the MassGeneral Hospital for Children, Professor of Surgery at Harvard Medical School, Director of the Laboratory for Tissue Engineering and Organ Fabrication, and the Department of Pediatric Transplantation at Massachusetts General Hospital.
Dr. Joseph Vacanti received his Bachelor of Science, summa cum laude, from Creighton University in 1970 and graduated first in his class. He received his MD, with high distinction, from University of Nebraska College of Medicine, and an MS from Harvard Medical School. He trained in General Surgery at the Massachusetts General Hospital, in Pediatric Surgery at Children's Hospital, Boston, and Transplantation at the University of Pittsburgh.
Dr. Vacanti has been working in the field of tissue engineering since its beginnings in the early 1980s - a mission that stems from his long-held interest in solving the problem of organ shortages. His approach to developing tissue involves a scaffold made of a biodegradable polymer, seeding it with living cells, and bathing it in growth factors. The cells can come from living tissue or stem cells. The cells multiply, filling the scaffold, and growing into a three-dimensional tissue. Once implanted in the body, the cells recreate their proper tissue function, blood vessels grow into the new tissue, the scaffold degrades, and lab-grown tissue becomes indistinguishable from its surroundings. Over the last 11 years, Dr. Vacanti has studied creating complete vascular networks as part of implantable tissue engineered devices which then allows the fabrication of large, complex living structures such as vital organs, extremities or craniofacial reconstruction.
Dr. Vacanti will address "2099 - A Look Back at Tissue Engineering and Regenerative Medicine in the 21st Century" on Tuesday, May 3rd.